Karo Pharma AB Stock
Karo Pharma AB Stock
Karo Pharma AB is currently one of the favorites of our community with 7 Buy predictions and no Sell predictions.
Based on the current price of 5.44 € the target price of 28 € shows a potential of 414.71% for Karo Pharma AB which would more than double the current price.
Pros and Cons of Karo Pharma AB in the next few years
Pros
?
M***** P*******
?
B****
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Karo Pharma AB vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Karo Pharma AB | - | - | - | - | - | - | - |
Medivir AB | 6.170% | -5.118% | 11.060% | -62.578% | 10.146% | -67.909% | -85.305% |
Active Biotech AB | -1.620% | 2.241% | -12.470% | -39.268% | 22.074% | -69.634% | -87.457% |
NanoViricides Inc. | -1.940% | 0.000% | -21.705% | -7.339% | 6.878% | -67.957% | -75.895% |
Comments
Karooooo Ltd. (NASDAQ: KARO) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $31.00 price target on the stock.
Show more
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its price target lowered by analysts at Morgan Stanley from $34.00 to $31.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its price target raised by analysts at Raymond James from $26.00 to $29.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for KARO provided by MarketBeat